BridgeMD
New treatment option for Hemodynamic
Official title Three Different GHDT ( Goal Hemodynamic Directed Therapy) Strategies for Intraoperative Fluid Management Optimization During Major Abdominal Surgery: A Randomized Controlled Trial
ClinicalTrials.gov ID: NCT06871150
What this study is testing
- What it's testing
- Major oncological surgery is among the most complex procedures, involving patients with a combination of high-risk factors that can significantly influence immediate postoperative outcomes and quality of life. The intraoperative hemodynamic management of these patients represents a crucial challenge: maintaining cardiovascular stability and fluid balance during the surgery is associated with reduced complications, including acute kidney injury, myocardial ischemia, and sepsis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Age ≥ 65 years.
- ASA physical status II-III-IV.
- Patients undergoing elective major abdominal oncological surgery.
- Revised Cardiac Index Score ≥ 2.
- Plan to perform the procedure with invasive arterial monitoring.
You likely can't join if
- Emergency or urgent surgeries.
- Severe chronic renal failure (creatinine clearance \< 30 ml/min).
- Chronic heart failure (NYHA Class IV).
- Pregnant women.
- Contraindications to pulse contour hemodynamic monitoring.
- Liver surgery.
See the full eligibility criteria
- Age ≥ 65 years.
- ASA physical status II-III-IV.
- Patients undergoing elective major abdominal oncological surgery.
- Revised Cardiac Index Score ≥ 2.
- Plan to perform the procedure with invasive arterial monitoring.
- Expected surgical time greater than 120 minutes.
- Emergency or urgent surgeries.
- Severe chronic renal failure (creatinine clearance \< 30 ml/min).
- Chronic heart failure (NYHA Class IV).
- Pregnant women.
- Contraindications to pulse contour hemodynamic monitoring.
- Liver surgery.
- Patient refusal.
The study team makes the final eligibility decision.
Where it's taking place
- Bergamo, Italy, Italy
- Rozzano, Italy, Italy
- Varese, Italy, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bergamo, Italy, Italy; Rozzano, Italy, Italy; Varese, Italy, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.